Search

Cecilia J. Tsang

Examiner (ID: 10028)

Most Active Art Unit
1202
Art Unit(s)
1611, 1202, 1675, 1811, 1625, 1654, 2899
Total Applications
1664
Issued Applications
1345
Pending Applications
72
Abandoned Applications
247

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5585073 [patent_doc_number] => 20090104275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Nanoencapsulation of Proteins' [patent_app_type] => utility [patent_app_number] => 11/563012 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 271 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104275.pdf [firstpage_image] =>[orig_patent_app_number] => 11563012 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/563012
Nanoencapsulation of Proteins Nov 22, 2006 Abandoned
Array ( [id] => 5625872 [patent_doc_number] => 20060264377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Chemically modified novel erythropoietin stimulating protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/498358 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 6874 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264377.pdf [firstpage_image] =>[orig_patent_app_number] => 11498358 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498358
Chemically modified novel erythropoietin stimulating protein compositions and methods Aug 1, 2006 Abandoned
Array ( [id] => 5760661 [patent_doc_number] => 20060211606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Peptides' [patent_app_type] => utility [patent_app_number] => 11/378624 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18890 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211606.pdf [firstpage_image] =>[orig_patent_app_number] => 11378624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378624
Peptides Mar 19, 2006 Abandoned
Array ( [id] => 5095540 [patent_doc_number] => 20070117149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 11/352782 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10925 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117149.pdf [firstpage_image] =>[orig_patent_app_number] => 11352782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352782
Carbon nanotube binding peptides Feb 12, 2006 Abandoned
Array ( [id] => 4727961 [patent_doc_number] => 20080207505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Bna Conjugates and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/813830 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37317 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207505.pdf [firstpage_image] =>[orig_patent_app_number] => 11813830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813830
Bna Conjugates and Methods of Use Jan 11, 2006 Abandoned
Array ( [id] => 4898873 [patent_doc_number] => 20080118487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Myostatin Isoform' [patent_app_type] => utility [patent_app_number] => 11/576449 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23987 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118487.pdf [firstpage_image] =>[orig_patent_app_number] => 11576449 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576449
Myostatin Isoform Sep 29, 2005 Abandoned
Array ( [id] => 5242830 [patent_doc_number] => 20070021325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability' [patent_app_type] => utility [patent_app_number] => 11/188217 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4204 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021325.pdf [firstpage_image] =>[orig_patent_app_number] => 11188217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/188217
Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability Jul 20, 2005 Abandoned
Array ( [id] => 5119406 [patent_doc_number] => 20070141120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Peptide having an ace inhibiting effect' [patent_app_type] => utility [patent_app_number] => 10/582759 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4632 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141120.pdf [firstpage_image] =>[orig_patent_app_number] => 10582759 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582759
Peptide having an ace inhibiting effect Nov 18, 2004 Abandoned
Array ( [id] => 7360143 [patent_doc_number] => 20040250301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transgenic animals' [patent_app_type] => new [patent_app_number] => 10/639754 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9241 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20040250301.pdf [firstpage_image] =>[orig_patent_app_number] => 10639754 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/639754
Transgenic animals Aug 12, 2003 Abandoned
Array ( [id] => 7397217 [patent_doc_number] => 20040038878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Injectable protein formulations' [patent_app_type] => new [patent_app_number] => 10/343487 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5632 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038878.pdf [firstpage_image] =>[orig_patent_app_number] => 10343487 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/343487
Injectable protein formulations Jan 30, 2003 Abandoned
Array ( [id] => 6830313 [patent_doc_number] => 20030181371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Compositions and methods of using collajolie' [patent_app_type] => new [patent_app_number] => 10/331125 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18839 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181371.pdf [firstpage_image] =>[orig_patent_app_number] => 10331125 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/331125
Compositions and methods of using collajolie Dec 26, 2002 Abandoned
Array ( [id] => 6653071 [patent_doc_number] => 20030105301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Separation of glyco-containing entities' [patent_app_type] => new [patent_app_number] => 10/275319 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4756 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105301.pdf [firstpage_image] =>[orig_patent_app_number] => 10275319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/275319
Separation of glyco-containing entities Nov 4, 2002 Abandoned
Array ( [id] => 6556047 [patent_doc_number] => 20020111496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Inhibitors of glycosyltransferase enzymes' [patent_app_type] => new [patent_app_number] => 10/067495 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111496.pdf [firstpage_image] =>[orig_patent_app_number] => 10067495 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/067495
Inhibitors of glycosyltransferase enzymes Feb 3, 2002 Abandoned
Array ( [id] => 7127830 [patent_doc_number] => 20050059574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Compositions of stable T3 and methodes of use thereof' [patent_app_type] => utility [patent_app_number] => 09/998346 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 6372 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09998346 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/998346
Compositions of stable T3 and methodes of use thereof Nov 29, 2001 Abandoned
Array ( [id] => 4010536 [patent_doc_number] => 05962477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Screening methods for cytokine inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/097441 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 46225 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962477.pdf [firstpage_image] =>[orig_patent_app_number] => 097441 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/097441
Screening methods for cytokine inhibitors Jun 14, 1998 Issued
Array ( [id] => 3943440 [patent_doc_number] => 05955057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Effervescing or foaming bath shape or solid' [patent_app_type] => 1 [patent_app_number] => 9/096517 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3681 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955057.pdf [firstpage_image] =>[orig_patent_app_number] => 096517 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/096517
Effervescing or foaming bath shape or solid Jun 11, 1998 Issued
Array ( [id] => 3939327 [patent_doc_number] => 05981479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Cyclosporins' [patent_app_type] => 1 [patent_app_number] => 9/084709 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7104 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981479.pdf [firstpage_image] =>[orig_patent_app_number] => 084709 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/084709
Cyclosporins May 25, 1998 Issued
Array ( [id] => 3951678 [patent_doc_number] => 05955572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Structural mimics of RGD-binding sites' [patent_app_type] => 1 [patent_app_number] => 9/079432 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10498 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955572.pdf [firstpage_image] =>[orig_patent_app_number] => 079432 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/079432
Structural mimics of RGD-binding sites May 13, 1998 Issued
Array ( [id] => 4048368 [patent_doc_number] => 05968903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Inhibition of H. pylori proliferation' [patent_app_type] => 1 [patent_app_number] => 9/074117 [patent_app_country] => US [patent_app_date] => 1998-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10469 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968903.pdf [firstpage_image] =>[orig_patent_app_number] => 074117 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/074117
Inhibition of H. pylori proliferation May 6, 1998 Issued
Array ( [id] => 3945560 [patent_doc_number] => 05977067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them' [patent_app_type] => 1 [patent_app_number] => 9/069959 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17492 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977067.pdf [firstpage_image] =>[orig_patent_app_number] => 069959 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/069959
Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them Apr 29, 1998 Issued
Menu